Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand ...

Elon Musk has revealed he has upgraded from Ozempic to Mounjaro, nicknamed the “King Kong” of weight-loss drugs, in a photo ...

A popular brand of eye drops is being recalled nationwide after a consumer reported a "foreign material" was found in a ...

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...

Duquesne Family Office's chief is cashing in his chips on two leading artificial intelligence (AI) stocks in favor of a ...

The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...

The federal government is phasing out off-brand copies of two blockbuster drugs used to treat obesity and diabetes.

Consumers who take copies of the weight loss drug Zepbound and diabetes drug Mounjaro will need to find a new source for ...

The majority of Teva's business lies in generic and off-patent branded drugs and faces price and volume pressures that will be exacerbated as regulatory actions and other players in the drug supply ...

Leukeran is only available as a brand-name drug. It doesn’t come in a generic version. A generic drug is an exact copy of the active ingredient in a brand-name medication. Generics tend to cost ...